Innovation, a pillar of the pharmaceutical industry

The Tunisian pharmaceutical industry is asserting itself as an essential engine of medical progress, combining expertise, innovation and commitment to quality. Discover how Tunisia, thanks to this dynamic sector, is helping to shape the future of healthcare.

● 2nd Health System in Africa in 2021.
● 2nd world destination in Thalassotherapy.
● 2nd in the field of health tourism in Africa.
● + 40 companies with foreign participation.
● + 13,500 direct jobs.

Tunisian exports of medicines to 35 countries around the world have tripled in 5 years. They now represent 18% of production. Supported by highly skilled human capital, this sector actively contributes to the economy and overall health. The Tunisian legislative and regulatory environment also offers considerable advantages for investors in the pharmaceutical sector.

Ibrahim MEDINI

Pharmaceutical project manager

(+216) 70 241 528

More than one good reason to invest in pharmaceuticals in Tunisia

Tunisia, a confirmed producer of medicines

Dive into an ecosystem of medical excellence in Tunisia, where health and medical tourism blend harmoniously to offer quality care and a unique experience to visitors.

Renowned health destination: Tunisia, ranked 2nd best health system in Africa, attracts patients from all over the world for its high-level medical services.
Therapeutic oases: Thalassotherapy centres, ranked 2nd in the world, offer revitalising treatments in an exceptional Mediterranean setting.
Pioneering capabilities: As a leader in health tourism in Africa, Tunisia offers a full range of medical services from cosmetic surgery to specialised treatments.
Medical innovation: Tunisia stands out for its advances in medical innovation, offering cutting-edge solutions in areas such as research, medical technology and alternative therapies.

Highly qualified human capital

The Tunisian pharmaceutical sector offers a unique combination of highly skilled talents at competitive costs, positioning the country as an attractive investment destination.

High-level human capital: Tunisia relies on a pool of skilled talents, with over 8,800 professionals employed in the sector. The average annual growth of 10% reflects the vitality and the value of the field.
Customised Training to Sector Needs: With over 18 public and private schools and institutions, Tunisia offers specific training programs designed to meet the requirements of the pharmaceutical sector, ensuring a qualified workforce.

Specialised graduates: Each year, more than 5,200 graduates are trained, with 36% being doctors and pharmacists, further enhancing the sector’s specialisation and its capacity for innovation.
Competitive costs: The average annual costs of Tunisian engineers, operators, and technicians remain highly competitive compared to the leading competing destinations, showcasing the profitability of investments in the pharmaceutical sector in Tunisia.

Innovation and collaboration

Tunisia is committed to the prosperity of the pharmaceutical industry, relying on fundamental pillars to stimulate innovation, collaboration and quality along the manufacturing and marketing chain.

Renowned research centres: Hubs such as the Biotechnological Technopole of Sidi Thabet, the Pasteur Institute of Tunis and the Biotechnology Center of Sfax form a dynamic ecosystem, promoting research and development.
Pharmaceutical pact: A strong commitment to improving the national ecosystem is consolidated by the pharmaceutical pact. Focused on infrastructure, governance, training, and investment, it strengthens the foundation of the sector.
Private partnership charter: An ambitious charter project, to be completed by 2025, aims to establish private partnerships in the pharmaceutical industry. This initiative will strengthen the sector’s competitiveness on an international scale.
Rigorous quality assurance system: The national Drug quality assurance system guarantees that production meets international standards, ensuring the quality and safety of Tunisian pharmaceutical products.